HU205550B - Process for producing pyroxycam solution of increased stability, free from effects damaging tussues - Google Patents

Process for producing pyroxycam solution of increased stability, free from effects damaging tussues

Info

Publication number
HU205550B
HU205550B HU907654A HU765490A HU205550B HU 205550 B HU205550 B HU 205550B HU 907654 A HU907654 A HU 907654A HU 765490 A HU765490 A HU 765490A HU 205550 B HU205550 B HU 205550B
Authority
HU
Hungary
Prior art keywords
tussues
pyroxycam
producing
free
solution
Prior art date
Application number
HU907654A
Other languages
English (en)
Other versions
HU907654D0 (en
Inventor
Kalmanne Nagy
Sandorne Szauder
Janos Egri
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Priority to HU907654A priority Critical patent/HU205550B/hu
Publication of HU907654D0 publication Critical patent/HU907654D0/hu
Priority to SU915010223A priority patent/RU2062616C1/ru
Priority to US07/797,963 priority patent/US5169847A/en
Priority to CS913600A priority patent/CZ281142B6/cs
Priority to ITMI913171A priority patent/IT1261955B/it
Priority to MYPI91002202A priority patent/MY108601A/en
Priority to JP3337733A priority patent/JPH04275222A/ja
Priority to AT0236791A priority patent/AT397462B/de
Priority to DE4139017A priority patent/DE4139017C2/de
Priority to RO148848A priority patent/RO113303B1/ro
Priority to SK3600-91A priority patent/SK278929B6/sk
Priority to GB9125268A priority patent/GB2250197B/en
Publication of HU205550B publication Critical patent/HU205550B/hu
Priority to CY180095A priority patent/CY1800A/xx
Priority to HU9500273P priority patent/HU211580A9/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU907654A 1990-11-27 1990-11-27 Process for producing pyroxycam solution of increased stability, free from effects damaging tussues HU205550B (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
HU907654A HU205550B (en) 1990-11-27 1990-11-27 Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
SU915010223A RU2062616C1 (ru) 1990-11-27 1991-11-26 Жидкая лекформа пироксикама
US07/797,963 US5169847A (en) 1990-11-27 1991-11-26 Drug solutions of increased stability and without tissue-damaging effect and process for preparing same
GB9125268A GB2250197B (en) 1990-11-27 1991-11-27 Piroxicam solutions of increased stability without tissue-damaging effect
JP3337733A JPH04275222A (ja) 1990-11-27 1991-11-27 安定性を強化したピロキシカム溶液、およびその製造方法
ITMI913171A IT1261955B (it) 1990-11-27 1991-11-27 Soluzione di farmaci in particolare piroxicam con stabilita' aumentatae senza effetto dannoso sui tessuti e procedimento per la loro preparazione
MYPI91002202A MY108601A (en) 1990-11-27 1991-11-27 Drug solutions of increased stability and without- tissuedamaging effect and process for preparing same
CS913600A CZ281142B6 (cs) 1990-11-27 1991-11-27 Roztoky léčiva se zvýšenou stabilitou a bez účinků poškozujících tkáň a způsob jejich přípravy
AT0236791A AT397462B (de) 1990-11-27 1991-11-27 Wässerige piroxicamlösungen
DE4139017A DE4139017C2 (de) 1990-11-27 1991-11-27 Wäßrige Piroxicam-Lösungen und Verfahren zu ihrer Herstellung
RO148848A RO113303B1 (ro) 1990-11-27 1991-11-27 Solutie de piroxicam, cu stabilitate marita
SK3600-91A SK278929B6 (sk) 1990-11-27 1991-11-27 Roztoky piroxikamu so zvýšenou stabilitou a bez úč
CY180095A CY1800A (en) 1990-11-27 1995-02-17 Piroxicam solutions of increased stability without tissue-damaging effect
HU9500273P HU211580A9 (hu) 1990-11-27 1995-06-20 Megnövelt stabilitású, szövetkárosító hatás nélküli piroxikam-oldatok Az átmeneti oltalom az 1., 2., 5. és 6. igénypontokra vonatkozik.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU907654A HU205550B (en) 1990-11-27 1990-11-27 Process for producing pyroxycam solution of increased stability, free from effects damaging tussues

Publications (2)

Publication Number Publication Date
HU907654D0 HU907654D0 (en) 1991-06-28
HU205550B true HU205550B (en) 1992-05-28

Family

ID=10972319

Family Applications (1)

Application Number Title Priority Date Filing Date
HU907654A HU205550B (en) 1990-11-27 1990-11-27 Process for producing pyroxycam solution of increased stability, free from effects damaging tussues

Country Status (13)

Country Link
US (1) US5169847A (hu)
JP (1) JPH04275222A (hu)
AT (1) AT397462B (hu)
CY (1) CY1800A (hu)
CZ (1) CZ281142B6 (hu)
DE (1) DE4139017C2 (hu)
GB (1) GB2250197B (hu)
HU (1) HU205550B (hu)
IT (1) IT1261955B (hu)
MY (1) MY108601A (hu)
RO (1) RO113303B1 (hu)
RU (1) RU2062616C1 (hu)
SK (1) SK278929B6 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ATE259220T1 (de) 1998-05-29 2004-02-15 Skyepharma Canada Inc Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
ID29270A (id) 1998-11-20 2001-08-16 Rtp Pharma Inc Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
GB2404336A (en) * 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
WO2007039417A1 (en) * 2005-09-30 2007-04-12 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.

Also Published As

Publication number Publication date
GB9125268D0 (en) 1992-01-29
DE4139017C2 (de) 2000-04-27
AT397462B (de) 1994-04-25
IT1261955B (it) 1996-06-11
RU2062616C1 (ru) 1996-06-27
ATA236791A (de) 1993-09-15
SK278929B6 (sk) 1998-04-08
ITMI913171A0 (it) 1991-11-27
GB2250197B (en) 1994-06-22
US5169847A (en) 1992-12-08
CY1800A (en) 1995-02-17
DE4139017A1 (de) 1992-06-04
HU907654D0 (en) 1991-06-28
MY108601A (en) 1996-10-31
ITMI913171A1 (it) 1992-05-28
GB2250197A (en) 1992-06-03
CS360091A3 (en) 1992-06-17
JPH04275222A (ja) 1992-09-30
CZ281142B6 (cs) 1996-06-12
RO113303B1 (ro) 1998-06-30

Similar Documents

Publication Publication Date Title
HU913664D0 (en) Process for the production of indian- and kinoline derivatives
HU910400D0 (en) Process for producing 3-aryl-carbonyl-1h-indole derivatives
HU911492D0 (en) Process for producing bis-aryl-amide and -urea derivatives
HU205550B (en) Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
EP0448194A3 (en) Process for production of polyarylenesulfides
HU910151D0 (en) Process for the production of substituted 2-chloride-pyridines
HU9200933D0 (en) Process for the production of kinoline derivatives
HU912639D0 (en) Process for producing (fluor-ethyl)-camptotecine derivatives
HU913280D0 (en) Process for the production of 8-chloro-kinoline derivatives
HU912693D0 (en) Process for producing indolo-naphtyridine derivatives
HU912732D0 (en) Process for producing 1-alkyl-isoquinoline derivatives
HU910937D0 (en) Process for the production of 8-sulfamylethylene-2-amino-tetraline derivatives
HU910326D0 (en) Process for producing 2-chloro-5-methyl-pyridine derivatives
HU913228D0 (en) Process for the production of 5-aroil-2,3-dihydro-1h-pyrrholyzine-1,1-dicarboxylates
HU910466D0 (en) Process for producing 7-amino-3-methoxy-methyl-cef-3-em-4-carboxylic acid
HUT58302A (en) Process for producing n-alkyl-sulfonal-amino-sulfonyl-urea derivatives
HUT58284A (en) Process for producing alkyl-sulfonanilide derivatives
HUT57734A (en) Process for producing pyrazaolecarboxylic acid derivatives
EP0485952A3 (en) Process for production of 3-amino-4-methylenepyrrolidine derivatives
HU905719D0 (en) Process for producing new amino-quinoline derivatives
HU907014D0 (en) Process for producing new 1-azabicycloalkane derivatives
HUT59374A (en) Process for producing rhodandoisubutyric acid
HU912412D0 (en) Process for producing n-alkyl-sulfonyl-amino-sulfonyl-urea derivatives
HU900082D0 (en) Process for manufacturing of conservated eggcomposition, mainly from quailegg
HU910614D0 (en) Process for producing 2-hydroxi-quinoxaline derivatives

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYRT., HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR, HU